Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.50 |
| ▸ | CASP3 | P42574 | 1/20 | 0.50 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1931125 | 0.88 | ALDH1A1 (0.78) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL420011 | 0.88 | ALDH1A1 (0.78) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5143403 | 0.87 | ALDH1A1 (0.75) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5169003 | 0.85 | ALDH1A1 (0.74) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5167895 | 0.85 | ALDH1A1 (0.74) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL14117855 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 | |
| Carbon Monoxide SCHEMBL9988779 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL5171094 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MAPK1CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL10407467 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL575835 | 0.83 | ALDH1A1 (0.70) | ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110130482-A1 | Process for preparing armatic thiophenyl ketones | PRETOR ROGER | 2011-06-02 | — | — | US | claimed |
| EP-1799638-B1 | PROCESS FOR PREPARING AROMATIC THIOPHENYL KETONES | CIBA HOLDING INC (CH) | 2008-07-30 | — | — | EP | claimed |
| EP-0150587-B1 | PREPARATION OF CHLOROBENZOTRIFLUORIDE COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-02-03 | — | — | EP | claimed |
| EP-0150587-A2 | Preparation of chlorobenzotrifluoride compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-08-07 | — | — | EP | claimed |
| JP-62132674-A | — | — | None | — | — | JP | disclosed |
| US-20250331405-A1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-10-23 | — | — | US | disclosed |
| CN-114685331-B | Process for producing 1, 2-dithioethane compound | 华南理工大学 | 2024-07-09 | — | — | CN | disclosed |
| CN-117567331-A | Synthesis method of 1, 2-dithioethane compound and 1, 4-dithiane | 河北北方学院 | 2024-02-20 | — | — | CN | disclosed |
| US-11872206-B2 | Purified forms of rofecoxib, methods of manufacture and use | Tremeau Pharmaceuticals, Inc. (US) | 2024-01-16 | — | — | US | disclosed |
| US-11617735-B2 | Purified forms of rofecoxib, methods of manufacture and use | Tremeau Pharmaceuticals, Inc. (US) | 2023-04-04 | — | — | US | disclosed |
| US-11576890-B2 | Purified forms of rofecoxib, methods of manufacture and use | Tremeau Pharmaceuticals, Inc. (US) | 2023-02-14 | — | — | US | disclosed |
| US-11559509-B2 | Purified forms of rofecoxib, methods of manufacture and use | Tremeau Pharmaceuticals, Inc. (US) | 2023-01-24 | — | — | US | disclosed |
| EP-0150587-B1 | PREPARATION OF CHLOROBENZOTRIFLUORIDE COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-02-03 | — | — | EP | disclosed |
| JP-S62132674-A | RECORDING MATERIAL | FUJI PHOTO FILM CO LTD | 1987-06-15 | — | — | JP | disclosed |
| EP-0222343-A2 | Recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1987-05-20 | — | — | EP | disclosed |
| EP-0150587-A2 | Preparation of chlorobenzotrifluoride compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-08-07 | — | — | EP | disclosed |
| US-4308403-A | FROM HYDROGEN, CARBON MONOXIDE, ALDEHYDE, ALCOHOL; COBALT COORDINATION CATALYST | TEXACO INC. (US) | 1981-12-29 | — | — | US | disclosed |
| US-4056480-A | DI-PHOSPHATES OR PHOSPHORAMIDATES | MONSANTO COMPANY (US) | 1977-11-01 | — | — | US | disclosed |
| US-3984340-A | POLYESTER EPOXIDES | MCDONNELL DOUGLAS CORPORATION (US) | 1976-10-05 | — | — | US | disclosed |
| US-3983046-A | Functional fluid compositions containing epoxy additives | MCDONNELL DOUGLAS CORPORATION (US) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11872206-B2 | Purified forms of rofecoxib, methods of manufacture and use | ITGA2B, F13B, F11 | ALDH1A1 2666/4885MAPK1 3214/4885CYP1A2 273/4885 |
| US-20110130482-A1 | Process for preparing armatic thiophenyl ketones | ACOT7, AGPAT2, COASY | ALDH1A1 1816/4885MAPK1 3795/4885CYP1A2 585/4885 |
| US-11617735-B2 | Purified forms of rofecoxib, methods of manufacture and use | ITGA2B, F13B, F11 | ALDH1A1 2666/4885MAPK1 3214/4885CYP1A2 273/4885 |
| US-11559509-B2 | Purified forms of rofecoxib, methods of manufacture and use | ITGA2B, F13B, F11 | ALDH1A1 2666/4885MAPK1 3214/4885CYP1A2 273/4885 |
| US-11576890-B2 | Purified forms of rofecoxib, methods of manufacture and use | ITGA2B, F13B, F11 | ALDH1A1 2666/4885MAPK1 3214/4885CYP1A2 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.